{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:32:45Z","timestamp":1777084365772,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermer\u00eda Intensiva"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.enfi.2010.01.004","type":"journal-article","created":{"date-parts":[[2010,4,23]],"date-time":"2010-04-23T09:01:35Z","timestamp":1272013295000},"page":"96-103","source":"Crossref","is-referenced-by-count":6,"title":["Compatibilidad visual y f\u00edsica de la furosemida en mezclas intravenosas para perfusi\u00f3n continua"],"prefix":"10.1016","volume":"21","author":[{"given":"E.","family":"P\u00e9rez Juan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Maqueda Palau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ar\u00e9valo Rubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ribas Nicolau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Amor\u00f3s Cerd\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.enfi.2010.01.004_bib1","first-page":"130","article-title":"C\u00f3mo y por qu\u00e9 estudiar la estabilidad de las mezclas de f\u00e1rmacos para uso i.v.. Procedimientos de investigaci\u00f3n","volume":"3","author":"Ortega Val\u00edn","year":"2006","journal-title":"Investig Clin Farm"},{"key":"10.1016\/j.enfi.2010.01.004_bib2","first-page":"54","article-title":"Perfusiones continuas de f\u00e1rmacos: \u00bfconocemos sus compatibilidades?","volume":"27","author":"Perez Juan","year":"2009","journal-title":"Nursing"},{"key":"10.1016\/j.enfi.2010.01.004_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.enfcli.2009.07.003","article-title":"Incompatibilidades en la terapia i.v.: \u00bfqu\u2032e hacer para prevenirlas?","author":"Secoli","year":"2009","journal-title":"Enferm Clin"},{"key":"10.1016\/j.enfi.2010.01.004_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.NURSE.0000266014.59320.2a","article-title":"Avoiding common perils of drug administration","volume":"37","author":"Rosenthal","year":"2007","journal-title":"Nursing"},{"key":"10.1016\/j.enfi.2010.01.004_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4037\/ccn2001.21.4.45","article-title":"Compatibility of commonly used intravenous infusions in a Pediatric Intensive Care Unit","volume":"21","author":"Wedekind","year":"2001","journal-title":"Crit Care Nurse"},{"key":"10.1016\/j.enfi.2010.01.004_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.NURSE.0000312600.67772.13","article-title":"What you should know about drug compatibility","volume":"38","author":"Rosenthal","year":"2008","journal-title":"Nursing"},{"key":"10.1016\/j.enfi.2010.01.004_bib7","first-page":"93","article-title":"Impacto nutriterap\u00e9utico de la interacci\u00f3n f\u00e1rmaco-nutriente","volume":"6","author":"Restrepo","year":"1998","journal-title":"Nuevos Tiempos"},{"key":"10.1016\/j.enfi.2010.01.004_bib8","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2146\/ajhp070471","article-title":"Standardization of infusion solutions to reduce the risk of incompatibility","volume":"65","author":"Nemec","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib9","volume":"Vol. 31","author":"Ho","year":"2007"},{"key":"10.1016\/j.enfi.2010.01.004_bib10","first-page":"45","article-title":"Evaluaci\u00f3n de un m\u00e9todo de cuantificaci\u00f3n de la concentraci\u00f3n de furosemida por cromatograf\u00eda en fase l\u00edquida de alta resoluci\u00f3n","volume":"26","author":"Blanco","year":"2007","journal-title":"SEQC"},{"key":"10.1016\/j.enfi.2010.01.004_bib11","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1097\/01.CCM.0000132892.51063.2F","article-title":"Diuretics and mortality in acute renal failure","volume":"32","author":"Shigehiko Uchino","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.enfi.2010.01.004_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000108641","article-title":"Frusemide administration in critically ill patients by continuous compared to bolus therapy","volume":"107","author":"Ostermann","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.enfi.2010.01.004_bib13","unstructured":"Rey C, de la Oliva P. Recursos terap\u00e9uticos. En: Ruza F, editores. Tratado de cuidados Intensivos Pedi\u00e1tricos. Vol. I., 3a ed., Norma-Capitel: Madrid; 2003; p. 1047\u20130."},{"key":"10.1016\/j.enfi.2010.01.004_bib14","unstructured":"AEMPS (Agencia Espa\u00f1ola de medicamentos y productos sanitarios) Ficha t\u00e9cnica de la furosemida. Disponible en: http:\/\/sinaem4.agemed.es\/consaem\/fichasTecnicas.do?metodo=detalleForm"},{"key":"10.1016\/j.enfi.2010.01.004_bib15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/ajhp\/58.6.504","article-title":"Visual compatibility of amiodarone hydrochloride injection with various intravenous drugs","volume":"58","author":"Chalmers","year":"2001","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib16","first-page":"1013","article-title":"An automated process for determining the physical compatibility of drugs","volume":"32","author":"Oskroba","year":"1997","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib17","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2146\/ajhp070471","article-title":"Standardization of infusion solutions to reduce the risk of incompatibility","volume":"65","author":"Nemec","year":"2008","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib18","first-page":"64","article-title":"Visual compatibility of drugs used in the intensive care unit","volume":"54","author":"Chiu","year":"1997","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib19","first-page":"1048","article-title":"Compatibility of selected critical care drugs during simulated Y-site administration","volume":"53","author":"Yamashita","year":"1996","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib20","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/ajhp\/54.15.1735","article-title":"Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration","volume":"54","author":"Trissel","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib21","first-page":"1325","article-title":"Drug precipitation within iv tubing: a potential hazard of chemotherapy administration","volume":"69","author":"Cohen","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.enfi.2010.01.004_bib22","series-title":"Mec\u00e1nica de los fluidos. Editado en Madrid","author":"White","year":"2004"},{"key":"10.1016\/j.enfi.2010.01.004_bib23","first-page":"939","article-title":"Compatibility of various admixtures with secondary additives at Y-site injection sites of intravenous administrations sets","volume":"34","author":"Allen","year":"1977","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib24","first-page":"2361","article-title":"Comparison of visual turbidim\u00e9trico methods for determining short-term compatibility of intravenosu critical-care drugs","volume":"45","author":"Dasta","year":"1988","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib25","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1093\/ajhp\/61.22.2415","article-title":"Compatibility of argatroban with selected cardiovascular agents","volume":"61","author":"Honisko","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib26","first-page":"96","article-title":"Assesment of injectable drugs\u2032administration in two intensive care units and determination of potential physic-chemical incompatibilities","volume":"12","author":"Serrurier","year":"2006","journal-title":"EJHPScience"},{"key":"10.1016\/j.enfi.2010.01.004_bib27","first-page":"380","article-title":"Compatibility of various admixtures withs secondary additives at Y-site injection sites of intravenous administrations sets. Part 2","volume":"38","author":"Allen","year":"1981","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib28","series-title":"Handbook of Injectable Drugs","author":"Trissel","year":"2003"},{"key":"10.1016\/j.enfi.2010.01.004_bib29","first-page":"123","article-title":"Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection","volume":"48","author":"Pugh","year":"1991","journal-title":"Am J Hosp Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib30","unstructured":"Humbert-Delaloye V, Voirol P, Gattlen L, Chiolero R, Pannatler A. Evaluation of intravenous drugs compatibilities in an adult ICU. 35th European Symposium on Clinical Pharmacy. [consultado 21\/10\/2006]. Disponible en: http:\/\/files.chuv.ch\/internet-docs\/pha\/recherche\/pha-escp-vd.pdf"},{"key":"10.1016\/j.enfi.2010.01.004_bib31","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/ajhp\/52.22.2567","article-title":"Visual compatibility of midazolam hydrochloridre with selected drugs during simulated Y\u2013site injection","volume":"52","author":"Mantong","year":"1995","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1023\/A:1008780126781","article-title":"Evaluation of physicochemical incompatibilities during parenteral drug administration in a paediatric intensive care unit","volume":"22","author":"Gikic","year":"2000","journal-title":"Pharmacy World Sicence"},{"key":"10.1016\/j.enfi.2010.01.004_bib33","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.2146\/ajhp040391","article-title":"Compatibility of argatroban with abciximab, eptifibatide, or tirofiban during simulated Y-site administration","volume":"62","author":"Patel","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.enfi.2010.01.004_bib34","unstructured":"AEMPS (Agencia Espa\u00f1ola de medicamentos y productos sanitarios) Ficha t\u00e9cnica de la furosemida. Disponible en: https:\/\/sinaem4.agemed.es\/\u2026\/especialidad.do?\u2026verFichaWordPdf\u2026FICHAS"}],"container-title":["Enfermer\u00eda Intensiva"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130239910000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130239910000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T23:59:34Z","timestamp":1591228774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130239910000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1130239910000349"],"URL":"https:\/\/doi.org\/10.1016\/j.enfi.2010.01.004","relation":{},"ISSN":["1130-2399"],"issn-type":[{"value":"1130-2399","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}